Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Aggressive Empiric Antibiotic Therapy on the Emergence of Antimicrobial Resistance During the Treatment of Ventilator-associated Pneumonia

NCT00050401 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00050401
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00050401 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Aggressive Empiric Antibiotic Therapy on the Emergence of Antimicrobial Resistance During the Treatment of Ventilator-associated Pneumonia
Lead sponsor
Pfizer
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2002
Completion date
September 30, 2004
Enrollment
500
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

pneumonia